Navco Pharmaceuticals (TSXV:NAV) Common Stock : C$0.32 Mil (As of Mar. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Navco Pharmaceuticals Common Stock?

Navco Pharmaceuticals's quarterly common stock stayed the same from Sep. 2022 (C$0.32 Mil) to Dec. 2022 (C$0.32 Mil) and stayed the same from Dec. 2022 (C$0.32 Mil) to Mar. 2023 (C$0.32 Mil).

Navco Pharmaceuticals's annual common stock stayed the same from Jun. 2019 (C$0.29 Mil) to Jun. 2020 (C$0.29 Mil) but then increased from Jun. 2020 (C$0.29 Mil) to Jun. 2021 (C$0.32 Mil).

Navco Pharmaceuticals Common Stock Historical Data

The historical data trend for Navco Pharmaceuticals's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Navco Pharmaceuticals Common Stock Chart

Navco Pharmaceuticals Annual Data

Trend

Jun18

Jun19

Jun20

Jun21

Common Stock

0.10

0.29

0.32

Navco Pharmaceuticals Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Common Stock	Get a 7-Day Free Trial														0.32	0.32	0.32	0.32	0.32

Navco Pharmaceuticals Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Navco Pharmaceuticals (TSXV:NAV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Navco Pharmaceuticals Inc (TSXV:NAV) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

1055 West Georgia Street, Suite 1500, Vancouver, BC, CAN, V6E 4N7

Website

Navco Pharmaceuticals Inc uses of nanotechnology to develop and commercialize novel products to protect against viruses, bacteria, and infectious diseases. The company's pipeline of applications is tailored to defend against pathogens utilizing new methods of action to capitalize on unmet product needs using natural & known compounds, nanoparticles, and no chemicals with a high degree of efficacy. Its target markets include human health & personal skin care, household & institutional products, and veterinary health.